Teva Parenteral Company Profile
What is the competitive landscape for TEVA PARENTERAL
TEVA PARENTERAL has forty-seven approved drugs.
There are six tentative approvals on TEVA PARENTERAL drugs.
Drugs and US Patents for Teva Parenteral
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Teva Parenteral | TOPOSAR | etoposide | INJECTABLE;INJECTION | 074166-001 | Feb 27, 1995 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Teva Parenteral | DOBUTAMINE HYDROCHLORIDE | dobutamine hydrochloride | INJECTABLE;INJECTION | 074206-001 | Oct 19, 1993 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Teva Parenteral | CYTARABINE | cytarabine | INJECTABLE;INJECTION | 016793-004 | Dec 21, 1987 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Teva Parenteral
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Teva Parenteral | CYTARABINE | cytarabine | INJECTABLE;INJECTION | 016793-001 | Approved Prior to Jan 1, 1982 | 3,444,294 | ⤷ Start Trial |
| Teva Parenteral | CYTARABINE | cytarabine | INJECTABLE;INJECTION | 016793-002 | Approved Prior to Jan 1, 1982 | 3,444,294 | ⤷ Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.

